HYDERABAD: A top CSIR-Cellular Molecular Biology Center (CCMB) official has said that the BF.7 variant of coronavirus in India is less likely to have a severe impact than in China as Indians have already acquired herd immunity. Is. Stressing the need to follow COVID-appropriate behavior, CCMB Director Vinay K Nandikuri said that there is always a concern that all these variants have the ability to evade the immune system and can infect those people as well. , who have been vaccinated, and even those who have been infected with the Omicron form.
He told the news agency PTI, “The infection of the current form is not as serious as the infection of the ‘delta form’ of the virus used to be. This is because we have herd immunity to an extent. We actually have ‘herd immunity’ because we are exposed to other viruses.
Media reports indicate that four cases of the BF.7 variant of the coronavirus have been reported in India. He said, “We (India) have seen a delta wave, which was very severe. We’ve had vaccinations and then the Omicron wave came and we’ve continued with preventive doses. We are different in many ways. What is happening in China cannot happen in India.
The Union Health Ministry said on Saturday that 201 new cases of Covid-19 were reported in India, while the number of patients under treatment increased to 3,397. The official said that the “zero covid policy” adopted by China is one of the main reasons for the rapid spread of the infection in the country. He said that the low rate of vaccination also increased the severity of the infection there.
Nandikuri said, “The rate of vaccination in India is high. Precautionary doses have also been given to the elderly and susceptible population at large. However, it cannot be claimed that there cannot be a wave of infection in India, but it does not seem that any wave of infection is coming immediately.
